Key result
Renin-angiotensin-aldosterone system inhibitors may interact with COVID-19 pathogenesis, as the SARS-CoV-2 virus uses angiotensin-converting enzyme 2 (ACE2) for host cell entry.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), main cause of coronavirus disease 2019 (COVID-19), uses the aminopeptidase angiotensin-converting enzyme 2 (ACE2) for entry into the ho...
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2020) studied this question. Renin-angiotensin-aldosterone system inhibitors may interact with COVID-19 pathogenesis, as the SARS-CoV-2 virus uses angiotensin-converting enzyme 2 (ACE2) for host cell entry.
Synapse has enriched 10 related papers. Consider them for comparative context: